NCT01871467View on ClinicalTrials.gov

Sargramostim for Myeloid Dendritic Cell Deficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Dendritic Cell Deficiency
Interventions
DRUG

Sargramostim

Trial Locations (1)

21205

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT01871467 - Sargramostim for Myeloid Dendritic Cell Deficiency | Biotech Hunter | Biotech Hunter